ONCE UPON A FARM PBC (OFRM) Fundamental Analysis & Valuation

NYSE:OFRM • US68237F1084

Current stock price

14.86 USD
+0.18 (+1.23%)
At close:
14.86 USD
0 (0%)
After Hours:

This OFRM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. OFRM Profitability Analysis

1.1 Basic Checks

  • In the past year OFRM has reported negative net income.
  • OFRM had a negative operating cash flow in the past year.
OFRM Yearly Net Income VS EBIT VS OCF VS FCFOFRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -14.82%, OFRM is doing worse than 72.41% of the companies in the same industry.
Industry RankSector Rank
ROA -14.82%
ROE N/A
ROIC N/A
ROA(3y)-25.59%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OFRM Yearly ROA, ROE, ROICOFRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 100 -100 200

1.3 Margins

  • The Gross Margin of OFRM (42.33%) is better than 96.55% of its industry peers.
  • OFRM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OFRM Yearly Profit, Operating, Gross MarginsOFRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. OFRM Health Analysis

2.1 Basic Checks

  • OFRM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OFRM has less shares outstanding
  • OFRM has a worse debt/assets ratio than last year.
OFRM Yearly Shares OutstandingOFRM Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 10M 20M 30M 40M
OFRM Yearly Total Debt VS Total AssetsOFRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • OFRM has an Altman-Z score of 3.57. This indicates that OFRM is financially healthy and has little risk of bankruptcy at the moment.
  • OFRM has a better Altman-Z score (3.57) than 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 3.57
ROIC/WACCN/A
WACC8.61%
OFRM Yearly LT Debt VS Equity VS FCFOFRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • OFRM has a Current Ratio of 2.33. This indicates that OFRM is financially healthy and has no problem in meeting its short term obligations.
  • OFRM has a better Current ratio (2.33) than 66.67% of its industry peers.
  • A Quick Ratio of 1.26 indicates that OFRM should not have too much problems paying its short term obligations.
  • The Quick ratio of OFRM (1.26) is better than 65.52% of its industry peers.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 1.26
OFRM Yearly Current Assets VS Current LiabilitesOFRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. OFRM Growth Analysis

3.1 Past

  • OFRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -323.43%.
  • The Revenue has grown by 53.49% in the past year. This is a very strong growth!
EPS 1Y (TTM)-323.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)53.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, OFRM will show a very strong growth in Earnings Per Share. The EPS will grow by 29.86% on average per year.
  • The Revenue is expected to grow by 23.35% on average over the next years. This is a very strong growth
EPS Next Y78.14%
EPS Next 2Y61.25%
EPS Next 3Y44.8%
EPS Next 5Y29.86%
Revenue Next Year27.4%
Revenue Next 2Y30.99%
Revenue Next 3Y29.18%
Revenue Next 5Y23.35%

3.3 Evolution

OFRM Yearly Revenue VS EstimatesOFRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
OFRM Yearly EPS VS EstimatesOFRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. OFRM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OFRM. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OFRM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OFRM Price Earnings VS Forward Price EarningsOFRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OFRM Per share dataOFRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • OFRM's earnings are expected to grow with 44.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.25%
EPS Next 3Y44.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OFRM Dividend Analysis

5.1 Amount

  • OFRM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OFRM Fundamentals: All Metrics, Ratios and Statistics

ONCE UPON A FARM PBC

NYSE:OFRM (4/24/2026, 8:04:00 PM)

After market: 14.86 0 (0%)

14.86

+0.18 (+1.23%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-12
Earnings (Next)05-07
Inst Owners13.47%
Inst Owner ChangeN/A
Ins Owners9.93%
Ins Owner Change18.39%
Market Cap622.34M
Revenue(TTM)240.68M
Net Income(TTM)-17.25M
Analysts80
Price Target28.85 (94.15%)
Short Float %9.58%
Short Ratio5.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-16.21%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS5.75
BVpS-0.53
TBVpS-0.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -14.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.33%
FCFM N/A
ROA(3y)-25.59%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover2.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 403.92%
Cap/Sales 2.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.33
Quick Ratio 1.26
Altman-Z 3.57
F-Score2
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)356.26%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.86%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-323.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y78.14%
EPS Next 2Y61.25%
EPS Next 3Y44.8%
EPS Next 5Y29.86%
Revenue 1Y (TTM)53.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year27.4%
Revenue Next 2Y30.99%
Revenue Next 3Y29.18%
Revenue Next 5Y23.35%
EBIT growth 1Y9.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year153.85%
EBIT Next 3Y112.76%
EBIT Next 5Y72.43%
FCF growth 1Y-150.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-170.83%
OCF growth 3YN/A
OCF growth 5YN/A

ONCE UPON A FARM PBC / OFRM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ONCE UPON A FARM PBC?

ChartMill assigns a fundamental rating of 2 / 10 to OFRM.


Can you provide the valuation status for ONCE UPON A FARM PBC?

ChartMill assigns a valuation rating of 1 / 10 to ONCE UPON A FARM PBC (OFRM). This can be considered as Overvalued.


Can you provide the profitability details for ONCE UPON A FARM PBC?

ONCE UPON A FARM PBC (OFRM) has a profitability rating of 1 / 10.


What is the financial health of ONCE UPON A FARM PBC (OFRM) stock?

The financial health rating of ONCE UPON A FARM PBC (OFRM) is 4 / 10.


What is the earnings growth outlook for ONCE UPON A FARM PBC?

The Earnings per Share (EPS) of ONCE UPON A FARM PBC (OFRM) is expected to grow by 78.14% in the next year.